Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

India Pharma Industry Objects To Plan For Increasing Drug Exports

This article was originally published in PharmAsia News

Executive Summary

India's pharmaceutical industry is highly critical of a government proposal to increase drug exports with a series of incentives to various firms. The head of the Indian Pharmaceutical Alliance, which represents the industry, said the plan could be counter-productive because it relies on funding initiatives for firms merely registering products with the government. The Department of Pharmaceuticals had proposed funding by venture capitalists and initiatives such as tax exemptions, import duty waivers and protection for clinical test data. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC072584

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel